Clinical Trial Duration
Cross-source consensus on Clinical Trial Duration from 1 sources and 5 claims.
1 sources · 5 claims
Evidence quality
Other
Highlighted claims
- Clinical trial duration was defined as the interval from first patient in to last patient last visit. — Association between decentralised clinical trial adoption and trial duration: a retrospective cross-sectional study of metabolic disease trials
- In ClinicalTrials.gov terms, CTD was measured from study start date to study completion date. — Association between decentralised clinical trial adoption and trial duration: a retrospective cross-sectional study of metabolic disease trials
- DCT adoption and its interaction with clinical phase were not significantly associated with shorter CTD. — Association between decentralised clinical trial adoption and trial duration: a retrospective cross-sectional study of metabolic disease trials
- The primary completion period captured the time needed to assess primary efficacy outcomes and was used in sensitivity analysis. — Association between decentralised clinical trial adoption and trial duration: a retrospective cross-sectional study of metabolic disease trials
- Clinical phase was significantly associated with CTD. — Association between decentralised clinical trial adoption and trial duration: a retrospective cross-sectional study of metabolic disease trials